FDA Approves Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine HCl) Oral Solution

Links shared publicly online about this topic.

  • 191
    total visits

FDA Approves Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine HCl) Oral Solution

drugs.com

Zutripro (chlorpheniramine, hydrocodone and pseudoephedrine) is used to relieve cough and nasal congestion. Includes Zutripro side effects, interactions and indications.

View full resource at drugs.com

Tags: Allergy Medication, Antihistamine, Cough, Drug, FDA, Decongestant, Sudafed

  • Share

Most Recently Shared on June 26, 2011 at 4:14 am By:

Drugs_Devices Drugs and Devices OW

FDA Approves Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine HCl) Oral Solu... http://bit.ly/l4dk7u #drug

11 months ago...

Zutripro and Rezira Available for Cough and Cold - MPR

empr.com — “Hawthorn and Cypress Pharmaceuticals announced that the FDA has approved Zutripro (hydrocodone bitartrate, chlorpheniramine maleate, and pseudoephedrine HCl oral solution) and Rezira (hydrocodone bitartrate and pseudoephedrine oral solution) for the relief of cough and nasal congestion associated with the common cold in adults ?18 years.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on June 14, 2011 at 4:48 pm By:

eMPR MPR Medical Publisher

MPR News: Zutripro and Rezira Available for Cough and Cold: Hawthorn and Cypress Pharmaceuticals announced that ... http://bit.ly/m4yD2X

12 months ago...

Zutripro and Rezira Available for Cough and Cold - ONA

oncologynurseadvisor.com — “Hawthorn and Cypress Pharmaceuticals announced that the FDA has approved Zutripro (hydrocodone bitartrate, chlorpheniramine maleate, and pseudoephedrine HCl oral solution) and Rezira (hydrocodone bitartrate and pseudoephedrine oral solution) for the relief of cough and nasal congestion associated with the common cold in adults ?18 years.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on June 14, 2011 at 4:35 pm By:

Advertisement